Drawing investor attention can pose a challenge, even for companies with groundbreaking, new science. In a space teeming with competition, it’s vital that emerging biophama companies developing innovative therapies also establish strong messaging to reach and intrigue potential investors.
Posts by Stephanie Carrington
Stephanie Carrington is a Managing Director on Westwicke's life sciences team. She has extensive experience in healthcare investor relations and strategic communications. She has a BA in economics and international relations from Smith College and an MBA in finance and international business from New York University’s Stern School of Business.
Clinical trial data disclosure can be tricky.
Download our checklist of 10 disclosure guidelines to minimize risk and maximize the impact of good news.